Variant report

Variant	esv1829750
Chromosome Location	chr2:33704194-33740571
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:776)
CpG islands
(count:366)
Chromatin interactive
region (count:12)
LncRNA
region (count:4)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:776 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr2:33704389-33704526	K562	blood:	n/a	n/a
2	ATF1	chr2:33721387-33721484	K562	blood:	n/a	n/a
3	ATF2	chr2:33708855-33709954	GM12878	blood:	n/a	n/a
4	ATF2	chr2:33718925-33720333	GM12878	blood:	n/a	n/a
5	ATF2	chr2:33708882-33709744	GM12878	blood:	n/a	n/a
6	ATF2	chr2:33723198-33724015	GM12878	blood:	n/a	n/a
7	ATF2	chr2:33718853-33720197	GM12878	blood:	n/a	n/a
8	ATF2	chr2:33713064-33714314	GM12878	blood:	n/a	n/a
9	ATF2	chr2:33713147-33714559	GM12878	blood:	n/a	n/a
10	ATF2	chr2:33722060-33724106	GM12878	blood:	n/a	n/a
11	ATF2	chr2:33722134-33722847	GM12878	blood:	n/a	n/a
12	ATF2	chr2:33703823-33704501	GM12878	blood:	n/a	n/a
13	BATF	chr2:33722296-33722707	GM12878	blood:	n/a	n/a
14	BATF	chr2:33719160-33719781	GM12878	blood:	n/a	chr2:33719505-33719516
15	BATF	chr2:33708823-33709684	GM12878	blood:	n/a	n/a
16	BATF	chr2:33722293-33722642	GM12878	blood:	n/a	n/a
17	BATF	chr2:33713681-33714208	GM12878	blood:	n/a	n/a
18	BATF	chr2:33713218-33714227	GM12878	blood:	n/a	n/a
19	BATF	chr2:33713236-33713664	GM12878	blood:	n/a	n/a
20	BATF	chr2:33735052-33735318	GM12878	blood:	n/a	chr2:33735154-33735165
21	BATF	chr2:33708905-33709680	GM12878	blood:	n/a	n/a
22	BATF	chr2:33723387-33723982	GM12878	blood:	n/a	n/a
23	BCL11A	chr2:33722275-33722615	GM12878	blood:	n/a	n/a
24	BCL11A	chr2:33719198-33719829	GM12878	blood:	n/a	chr2:33719505-33719514
25	BCL11A	chr2:33708967-33709330	GM12878	blood:	n/a	n/a
26	BCL11A	chr2:33709353-33709721	GM12878	blood:	n/a	chr2:33709507-33709516
27	BCL11A	chr2:33722200-33722730	GM12878	blood:	n/a	n/a
28	BCL11A	chr2:33713714-33714167	GM12878	blood:	n/a	chr2:33713931-33713940
29	BCL3	chr2:33722177-33722706	GM12878	blood:	n/a	n/a
30	BCL3	chr2:33709272-33709694	GM12878	blood:	n/a	chr2:33709507-33709516
31	BCL3	chr2:33719047-33719775	GM12878	blood:	n/a	chr2:33719505-33719514
32	BCL3	chr2:33713210-33714444	GM12878	blood:	n/a	chr2:33713931-33713940
33	BCLAF1	chr2:33722144-33724147	GM12878	blood:	n/a	n/a
34	BCLAF1	chr2:33719110-33719758	GM12878	blood:	n/a	chr2:33719505-33719514
35	BCLAF1	chr2:33719047-33719913	GM12878	blood:	n/a	chr2:33719505-33719514
36	BCLAF1	chr2:33703642-33705098	GM12878	blood:	n/a	n/a
37	BCLAF1	chr2:33713169-33714182	GM12878	blood:	n/a	chr2:33713931-33713940
38	BCLAF1	chr2:33708967-33709959	GM12878	blood:	n/a	chr2:33709507-33709516
39	BCLAF1	chr2:33727048-33727384	GM12878	blood:	n/a	n/a
40	BCLAF1	chr2:33712759-33714256	GM12878	blood:	n/a	chr2:33713931-33713940
41	BCLAF1	chr2:33722214-33722777	GM12878	blood:	n/a	n/a
42	BHLHE40	chr2:33722229-33723005	GM12878	blood:	n/a	n/a
43	BHLHE40	chr2:33704570-33705069	GM12878	blood:	n/a	n/a
44	BHLHE40	chr2:33713084-33714178	GM12878	blood:	n/a	n/a
45	BHLHE40	chr2:33719212-33719843	GM12878	blood:	n/a	n/a
46	BHLHE40	chr2:33708935-33709967	GM12878	blood:	n/a	n/a
47	CEBPB	chr2:33728985-33729057	A549	lung:	n/a	chr2:33728990-33728999
48	CEBPB	chr2:33736255-33736634	IMR90	lung:	n/a	chr2:33736454-33736466 chr2:33736594-33736606
49	CEBPB	chr2:33713181-33714633	GM12878	blood:	n/a	n/a
50	CEBPB	chr2:33721083-33721606	IMR90	lung:	n/a	chr2:33721221-33721234

(count:366 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:33738079-33738129	PrEC	prostate:	n/a
2	chr2:33738782-33738832	RPTEC	kidney:	n/a
3	chr2:33738079-33738129	MCF10A-Er-Src	breast:	n/a
4	chr2:33720546-33720596	ovcar-3	ovarian:	n/a
5	chr2:33738079-33738129	HCM	heart:	n/a
6	chr2:33738782-33738832	HEK293	kidney:	embryo
7	chr2:33738079-33738129	ProgFib	skin:	n/a
8	chr2:33720546-33720596	AG04449	skin:	fetal
9	chr2:33740191-33740241	NHDF-neo	bronchial:	n/a
10	chr2:33720546-33720596	Hepatocyte	liver:	n/a
11	chr2:33738079-33738129	HEK293	kidney:	embryo
12	chr2:33738782-33738832	BJ	skin:	n/a
13	chr2:33720546-33720596	HEEpiC	esophagus:	n/a
14	chr2:33735888-33735938	IMR90	lung:	fetal
15	chr2:33738782-33738832	ProgFib	skin:	n/a
16	chr2:33738079-33738129	BE2_C	brain:	n/a
17	chr2:33738782-33738832	Hepatocyte	liver:	n/a
18	chr2:33738782-33738832	AG09319	gingival:	n/a
19	chr2:33720546-33720596	GM12878	blood:	n/a
20	chr2:33738079-33738129	AG04449	skin:	fetal
21	chr2:33740191-33740241	AG09309	skin:	n/a
22	chr2:33738079-33738129	H1-hESC	embryonic stem cell:	embryo
23	chr2:33720546-33720596	H1-hESC	embryonic stem cell:	embryo
24	chr2:33740191-33740241	Hela-S3	cervix:	n/a
25	chr2:33738782-33738832	MCF10A-Er-Src	breast:	n/a
26	chr2:33740191-33740241	GM12878	blood:	n/a
27	chr2:33738782-33738832	SAEC	small airway:	n/a
28	chr2:33738782-33738832	T-47D	breast:	n/a
29	chr2:33738782-33738832	GM19239	blood:	n/a
30	chr2:33735888-33735938	SK-N-MC	brain:	n/a
31	chr2:33737453-33737503	AoSMC	blood vessel:	n/a
32	chr2:33738079-33738129	AoSMC	blood vessel:	n/a
33	chr2:33738079-33738129	SK-N-MC	brain:	n/a
34	chr2:33737453-33737503	HAEpiC	amniotic membrane:	n/a
35	chr2:33738782-33738832	NHBE	bronchial:	n/a
36	chr2:33735888-33735938	HepG2	liver:	n/a
37	chr2:33738079-33738129	AG10803	skin:	n/a
38	chr2:33720546-33720596	HCT-116	colon:	n/a
39	chr2:33735888-33735938	PANC-1	pancreas:	n/a
40	chr2:33720546-33720596	RPTEC	kidney:	n/a
41	chr2:33738782-33738832	LNCaP	prostate:	n/a
42	chr2:33740191-33740241	HCT-116	colon:	n/a
43	chr2:33738079-33738129	T-47D	breast:	n/a
44	chr2:33740191-33740241	HepG2	liver:	n/a
45	chr2:33738782-33738832	AoSMC	blood vessel:	n/a
46	chr2:33720546-33720596	AoSMC	blood vessel:	n/a
47	chr2:33737453-33737503	SK-N-SH	brain:	n/a
48	chr2:33737453-33737503	NHBE	bronchial:	n/a
49	chr2:33740191-33740241	AG04449	skin:	fetal
50	chr2:33738782-33738832	NH-A	brain:	n/a

(count:12 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:33718664..33721605-chr2:33823247..33825969,2	MCF-7	breast:
2	chr2:33702588..33705548-chr2:33744716..33747266,2	K562	blood:
3	chr2:33708290..33711080-chr2:33714152..33717140,3	K562	blood:
4	chr2:33724900..33727027-chr2:33748735..33751257,2	K562	blood:
5	chr2:33700002..33701535-chr2:33708828..33711417,2	K562	blood:
6	chr2:33708290..33711080-chr2:33714152..33717140,3	K562	blood:
7	chr2:33732568..33734531-chr2:33737995..33739740,2	K562	blood:
8	chr2:33729626..33732550-chr2:33733058..33735608,2	K562	blood:
9	chr2:33721073..33722993-chr2:33725616..33728253,2	K562	blood:
10	chr2:33736575..33738622-chr2:33744601..33747381,2	K562	blood:
11	chr2:33729626..33732550-chr2:33733058..33735608,2	K562	blood:
12	chr2:33721073..33722993-chr2:33725616..33728253,2	K562	blood:

(count:4 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-LTBP1-1	chr2:33736777-33736909	NONHSAT070012
2	lnc-LTBP1-1	chr2:33706250-33707081	NONHSAT070015
3	lnc-LTBP1-1	chr2:33706250-33706371	NONHSAT070012
4	lnc-LTBP1-1	chr2:33706250-33708003	NONHSAT070011

No data

Variant related genes	Relation type
RASGRP3	TF binding region
RASGRP3	CpG island
ENSG00000152689	chromatin interactions
ENSG00000119812	chromatin interactions

Extended variants
information (count: 1597 )
Associated
traits (count: 62 )

Variant overlapped rSNPs/rCNVs (count:1597 , 50 per page) page: 1 2 3 4 5 6 7 ... 32

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs536191614	chr2:33704194-33704195	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs150511455	chr2:33704238-33704239	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs530613826	chr2:33704266-33704267	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs58876646	chr2:33704273-33704274	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs116607760	chr2:33704320-33704321	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs533216483	chr2:33704337-33704338	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs188586753	chr2:33704381-33704382	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs566046283	chr2:33704399-33704400	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs535155226	chr2:33704411-33704412	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs554745308	chr2:33704430-33704431	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs150169904	chr2:33704478-33704479	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs77939222	chr2:33704479-33704480	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs397756274	chr2:33704482-33704483	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs368510608	chr2:33704483-33704484	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs568685871	chr2:33704523-33704524	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs537241707	chr2:33704532-33704533	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs557095173	chr2:33704548-33704549	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs373173533	chr2:33704553-33704554	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs371582942	chr2:33704573-33704574	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs193161065	chr2:33704593-33704594	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs373592319	chr2:33704595-33704596	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs546051441	chr2:33704598-33704599	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs79556224	chr2:33704618-33704619	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs572726881	chr2:33704633-33704634	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs541953934	chr2:33704636-33704637	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs561618568	chr2:33704693-33704694	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs575258619	chr2:33704732-33704733	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs141693050	chr2:33704759-33704760	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs79369369	chr2:33704761-33704762	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs6543716	chr2:33704785-33704786	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs577333882	chr2:33704798-33704799	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs6729814	chr2:33704833-33704834	Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs546903102	chr2:33704849-33704850	Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs559726965	chr2:33704868-33704869	Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs528475602	chr2:33704875-33704876	Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs112286234	chr2:33704883-33704884	Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs541274853	chr2:33704910-33704911	Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs548707125	chr2:33704922-33704923	Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs146341379	chr2:33704941-33704942	Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs568473756	chr2:33704946-33704947	Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs11694023	chr2:33704950-33704951	Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs6758325	chr2:33704969-33704970	Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs6744772	chr2:33704976-33704977	Weak transcription Enhancers Transcr. at gene 5' and 3' Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs539771200	chr2:33705016-33705017	Weak transcription Enhancers Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs553247661	chr2:33705039-33705040	Weak transcription Enhancers Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs572835137	chr2:33705054-33705055	Weak transcription Enhancers Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs542269066	chr2:33705061-33705062	Weak transcription Enhancers Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs535401218	chr2:33705070-33705071	Weak transcription Enhancers Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs548941781	chr2:33705084-33705085	Weak transcription Enhancers Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs184024877	chr2:33705086-33705087	Weak transcription Enhancers Genic enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:62)

Disease	PMID	Source
Breast cancer	17393978	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Breast cancer	17603634	CNVD
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17387387	CNVD
Neuroblastoma	17533364	CNVD
Neuroblastoma	18923191	CNVD
Endometrial cancer	22040021	CNVD
Adrenal tumor	17535989	CNVD
Breast cancer	21264507	CNVD
Basal cell lymphoma	17053054	CNVD
Medulloblastoma	17522785	CNVD
Cancer	23418310	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
lymphocytic leukemia	21291569	CNVD
Prostate cancer	18632612	CNVD
Bladder cancer	21909424	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Autism	22495311	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	20505157	CNVD
Autism	17483303	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Medulloblastoma	20607354	CNVD
Leukemia	18628472	CNVD
Autism	19521722	CNVD
Autism	18522746	CNVD
Breast cancer	21364760	CNVD
Wilms tumour	21544195	CNVD
Non-small cell lung cancer	18927303	CNVD
Hereditary gingival fibromatosis	19633868	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21785460	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	21045282	CNVD
Prostate cancer	21965145	CNVD
Breast cancer	16397240	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21508638	CNVD
Neurodevelopmental disorder	22521361	CNVD
Neurocytoma	17123091	CNVD
Autism	22495309	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:570 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:33700800-33705600	Active TSS	GM12878-XiMat	blood
2	chr2:33701800-33704800	Flanking Active TSS	Primary B cells from cord blood	blood
3	chr2:33702000-33704400	Weak transcription	Gastric	stomach
4	chr2:33702200-33705600	Enhancers	Fetal Adrenal Gland	Adrenal Gland
5	chr2:33702800-33704600	Active TSS	Rectal Mucosa Donor 29	rectum
6	chr2:33702800-33705400	Weak transcription	Placenta	Placenta
7	chr2:33702800-33705600	Enhancers	Fetal Muscle Leg	muscle
8	chr2:33702800-33707600	Weak transcription	Duodenum Smooth Muscle	Duodenum
9	chr2:33703000-33704200	Weak transcription	Stomach Mucosa	stomach
10	chr2:33703000-33704600	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
11	chr2:33703000-33704600	Bivalent Enhancer	HUVEC	blood vessel
12	chr2:33703000-33704800	Flanking Active TSS	Primary B cells from peripheral blood	blood
13	chr2:33703000-33707400	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
14	chr2:33703000-33707400	Weak transcription	HSMMtube	muscle
15	chr2:33703200-33704200	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
16	chr2:33703200-33704200	Weak transcription	Brain Angular Gyrus	brain
17	chr2:33703200-33704200	Weak transcription	Brain Inferior Temporal Lobe	brain
18	chr2:33703200-33704400	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
19	chr2:33703200-33704400	Weak transcription	Lung	lung
20	chr2:33703200-33704600	Active TSS	Primary Natural Killer cells fromperipheralblood	blood
21	chr2:33703200-33705000	Active TSS	Duodenum Mucosa	Duodenum
22	chr2:33703200-33705600	Enhancers	Adipose Nuclei	Adipose
23	chr2:33703200-33705800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
24	chr2:33703200-33707600	Weak transcription	Breast Myoepithelial Primary Cells	Breast
25	chr2:33703200-33707600	Weak transcription	NHDF-Ad	bronchial
26	chr2:33703200-33708600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
27	chr2:33703200-33709200	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
28	chr2:33703400-33704200	Enhancers	Primary hematopoietic stem cells	blood
29	chr2:33703400-33704200	Enhancers	Skeletal Muscle Male	skeletal muscle
30	chr2:33703400-33704200	Enhancers	K562	blood
31	chr2:33703400-33704400	Enhancers	Brain Substantia Nigra	brain
32	chr2:33703400-33704400	Weak transcription	Pancreas	Pancrea
33	chr2:33703400-33704400	Weak transcription	Rectal Smooth Muscle	rectum
34	chr2:33703400-33704400	Weak transcription	Right Atrium	heart
35	chr2:33703400-33704400	Weak transcription	Right Ventricle	heart
36	chr2:33703400-33705400	Enhancers	Primary hematopoietic stem cells short term culture	blood
37	chr2:33703400-33706000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
38	chr2:33703400-33706200	Enhancers	Brain Anterior Caudate	brain
39	chr2:33703400-33706200	Enhancers	Brain Cingulate Gyrus	brain
40	chr2:33703600-33704400	Active TSS	Brain Hippocampus Middle	brain
41	chr2:33703600-33704800	Weak transcription	Monocytes-CD14+_RO01746	blood
42	chr2:33703600-33705800	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
43	chr2:33703600-33708800	Weak transcription	Fetal Muscle Trunk	muscle
44	chr2:33703600-33711800	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
45	chr2:33703600-33715600	Weak transcription	Spleen	Spleen
46	chr2:33703800-33704200	Active TSS	Primary T helper cells PMA-I stimulated	--
47	chr2:33703800-33704200	Flanking Active TSS	Fetal Heart	heart
48	chr2:33703800-33704800	Weak transcription	Primary monocytes fromperipheralblood	blood
49	chr2:33704000-33704400	Enhancers	Skeletal Muscle Female	skeletal muscle
50	chr2:33704000-33705600	Enhancers	Left Ventricle	heart

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links